WuXi Biologics (Cayman) (WXXWY) Expected to Announce Quarterly Earnings on Tuesday

WuXi Biologics (Cayman) (OTCMKTS:WXXWY) is expected to announce its resultson Tuesday, August 25th. Analysts expect WuXi Biologics (Cayman) to post earnings of $0.1330 per share and revenue of $1.6950 billion for the quarter.

WuXi Biologics (Cayman) Stock Up 2.5%

Shares of OTCMKTS WXXWY opened at $12.91 on Friday. WuXi Biologics has a 1 year low of $7.30 and a 1 year high of $13.00. The business has a 50-day moving average of $9.83 and a two-hundred day moving average of $9.28.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.